A066700 logo

Theragen Etex Co.,Ltd. Stock Price

KOSDAQ:A066700 Community·₩77.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A066700 Share Price Performance

₩2,115.00
-835.00 (-28.31%)
₩2,115.00
-835.00 (-28.31%)
Price ₩2,115.00

A066700 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and slightly overvalued.

2 Risks
2 Rewards

Theragen Etex Co.,Ltd. Key Details

₩272.9b

Revenue

₩131.7b

Cost of Revenue

₩141.2b

Gross Profit

₩131.5b

Other Expenses

₩9.7b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
265.24
51.74%
3.57%
26.8%
View Full Analysis

About A066700

Founded
1987
Employees
n/a
CEO
Ko Jin-Up
WebsiteView website
www.theragenetex.com

Theragen Etex Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products in Korea. It offers drugs in the fields of circulatory, respiratory, digestive, antibiotics, antifungals, analgesic, endocrine and metabolic, hepatoprotective, psychotropic, urinary system, skeletal muscle, PMS, anthelmintic, nutrition, and others. The company was formerly known as Theragen Co., Ltd. and changed its name to Theragen Etex Co.,Ltd. in July 2010. Theragen Etex Co.,Ltd. was founded in 1987 and is headquartered in Seoul, South Korea.

Recent A066700 News & Updates

Analysis Article Apr 01

Theragen EtexLtd's (KOSDAQ:066700) Shareholders Should Assess Earnings With Caution

We didn't see Theragen Etex Co.,Ltd.'s ( KOSDAQ:066700 ) stock surge when it reported robust earnings recently. We...

Recent updates

No updates